Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation

Blood

Volumn 89, Issue 1, 1997, Pages 297-306

  Heaney, Conor ^a   Kolibaba, Kathryn ^a   Bhat, Arun ^a   Oda, Tsukasa ^a   Ohno, Sayuri ^a   Fanning, Shane ^a   Druker, Brian J ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TYROSINE;

AMINO TERMINAL SEQUENCE; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; DELETION MUTANT; GROWTH REGULATION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION;

EID: 0031038399     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.1.297.297_297_306     Document Type: Article

References (49)

1. Rowley JD: A new consistent abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and giemsa staining. Nature 243:290, 1973
2. Nowell PC, Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science 132:1497, 1960
3. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G: Philadelphia chromosome breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36:93, 1984
4. Heisterkamp N, Stam K, Groffen J, de Klein A, Grosveld G: Structural organization of the bcr gene and its role in the Ph′ translocation. Nature 315:758, 1985
5. Ben-Neriah Y, Daley GQ, Mes-Masson A-M, Witte ON, Baltimore D: The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Science 233:212, 1986
6. Daley GQ, McLaughlin J, Witte ON, Baltimore D: The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/ 3T3 fibroblasts. Science 237:532, 1987
7. Davis RL, Konopka JB, Witte ON: Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties. Mol Cell Biol 5:204, 1985
8. Lugo TG, Pendergast AM, Muller AJ, Witte ON: Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247:1079, 1990
9. Lugo TG, Witte ON: The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc. Mol Cell Biol 9:1263, 1989
10. McLaughlin J, Chianese E, Witte ON: In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome. Proc Natl Acad Sci USA 84:6558, 1987
11. Young JC, Witte ON: Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures. Mol Cell Biol 8:4079, 1988
12. Daley GQ, Baltimore D: Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc Natl Acad Sci USA 85:9312, 1988
13. Laneuville P, Heisterkamp N, Groffen J: Expression of the chronic myelogenous leukemia-associated p210bcr/abl oncoprotein in a murine IL-3 dependent myeloid cell line. Oncogene 6:275, 1991
14. Kelliher MA, McLaughlin J, Witte ON, Rosenberg N: Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR-ABL. Proc Natl Acad Sci USA 87:6649, 1990
15. Daley GQ, Van Etten RA, Baltimore D: Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247:824, 1990
16. Oda T, Tamura S, Matsuguchi T, Griffin JD, Druker BJ: The SH2 domain of Abl is not required for factor independent growth induced by Bcr-Abl in a murine myeloid cell line. Leukemia 9:295, 1995
17. Oda T, Heaney C, Hagopian J, Okuda K, Griffin JD, Druker BJ: CRKL is the major tyrosine phosphorylated protein in neutrophils from patients with chronic myleogenous leukemia. J Biol Chem 269:22925, 1994
18. ten Hoeve J, Arlinghaus RB, Guo JQ, Heisterkamp N: Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia. Blood 84:1731, 1994
19. Nichols GL, Raines MA, Vera JC, Lacomis L, Tempst P, Golde DW: Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells. Blood 84:2912, 1994
20. Mayer BJ, Hamaguchi M, Hanafusa H: A novel viral oncogene with structural similarity to phospholipase C. Nature 332:272, 1988
21. Matsuda M, Tanaka S, Nagata S, Kojima A, Kurata T, Shibuya M: Two species of human CRK cDNA encode proteins with distinct biological activities. Mol Cell Biol 12:3482, 1992
22. ten Hoeve J, Kaartinen V, Fioretos T, Haataja L, Voncken J-W, Heisterkamp N, Groffen J: Cellular interactions of CRKL, an SH2-SH3 adaptor protein. Cancer Res 54:2563, 1994
23. BCR-ABL tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line. Oncogene 9:149, 1994
24. Druker BJ, Roberts TM: Generation of a large library of point mutations in polyoma middle T antigen. Nucleic Acids Res 19:6855, 1991
25. Druker BJ, Mamon HJ, Roberts TM: Oncogenes, growth factors, and signal transduction. N Engl J Med 321:1383, 1989
26. Kanakura Y, Druker B, Cannistra SA, Furukawa Y, Torimoto Y, Griffin JD: Signal transduction of the human granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors involves a common set of cytoplasmic proteins. Blood 76:706, 1990
27. Greenberger JS, Sakakeeny MA, Humphries RK, Eaves CJ, Eckner RJ: Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci USA 80:2391, 1983
28. Mossman T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55, 1983
29. Vojtek AB, Hollenberg SM, Cooper JA: Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74:205, 1993
30. Ren R, Ye Z-S, Baltimore D: Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3 domains. Genes Dev 8:783, 1994
31. Feller SM, Ren R, Hanafusa H, Baltimore D: SH2 and SH3 domains as molecular adhesives: The interactions of Crk and Abl. Trends Biochem Sci 19:453, 1994
32. Senechal K, Halpern J, Druker BJ, Sawyers CL: Role of the CRKL adaptor protein in BCR-ABL transformation. Blood 86:1737a, 1995 (abstr, suppl 1)
33. Druker B, Okuda K, Matulonis U, Salgia R, Roberts T, Griffin JD: Tyrosine phosphorylation of rasGAP and associated proteins in chronic myelogenous leukemia cell lines. Blood 79:2215, 1992
34. Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J, Gishizky ML: BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 75:175, 1993
35. Puil L, Liu J, Gish G, Mbamalu G, Botwell D, Pelicci PG, Arlinghaus R, Pawson T: Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J 13:764, 1994
36. Tauchi T, Boswell HS, Leiboweitz D, Broxmeyer HE: Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway. J Exp Med 179:167, 1994
37. Matsuguchi T, Salgia R, Hallek M, Eder M, Druker B, Ernst T, Griffin JD: SHC phosphorylation in myeloid cells is regulated by GM-CSF, IL-3, and steel factor and is constitutively increased by p210BCR-ABL. J Biol Chem 269:5016, 1994
38. Ernst TJ, Slattery KE, Griffin JD: p210Bcr/Abl and p160v-Abl induce an increase in the tyrosine phosphorylation of p93c-Fes. J Biol Chem 269:5764, 1994
39. Tauchi T, Feng GS, Shen R, Song HY, Donner D, Pawson T, Broxmeyer HE: SH2-containing phosphotyrosine phosphatase Syp is a target of p210bcr-abl tyrosine kinase. J Biol Chem 269:15381, 1994
40. Andoniou CE, Thien CB, Langdon WY: Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. EMBO J 13:4515, 1994
41. de Jong R, ten Hoeve J, Heisterkamp N, Groffen J: Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia. J Biol Chem 270:21468, 1995
42. Ribon V, Hubbell S, Herrera R, Saltiel AR: The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner. Mol Cell Biol 16:45, 1996
43. Varticovski L, Daley GQ, Jackson P, Baltimore D, Cantley LC: Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants. Mol Cell Biol 11:1107, 1991
44. Matsuguchi T, Inhorn R, Carlesso N, Xu G, Druker B, Griffin JD: Tyrosine phosphorylation of vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL. EMBO J 14:257, 1995
45. Lu D, Liu J, Campbell M, Guo JQ, Heisterkamp N, Groffen J, Canaani E, Arlinghaus R: Tyrosine phosphorylation of p160 BCR by p210 BCR-ABL. Blood 82:1257, 1993
46. Salgia R, Li JL, Lo SH, Brunkhorst B, Kansas GS, Sobhany ES, Sun Y, Pisick E, Hallek M, Ernst T, Chen LB, Griffin JD: Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL. J Biol Chem 270:5039, 1995
47. Salgia R, Brunkhorst B, Pisick E, Li JL, Lo SH, Chen LB, Griffin JD: Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cells expressing p210BCR-ABL. Oncogene 11:1149, 1995
48. Sattler M, Salgia R, Okuda K, Uemura N, Durstin MA, Pisick E, Xu G, Li JL, Prasad KV, Griffin JD: The proto-oncogene product p120cbl and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR-ABL and p210BCR-ABL to the phosphatidylinositol-3′ kinase pathway. Oncogene 12:839, 1996
49. Fukazawa T, Reedquist KA, Trub T, Soltoff S, Panchamoorthy G, Druker B, Cantley L, Shoelson SE, Band H: The SH3 domainbinding T cell tyrosyl phosphoprotein p120: Demonstration of its identity with the c-cbl protooncogene product and in vivo complexes with Fyn, Grb2 and phosphatidylinositol 3-kinase. J Biol Chem 270:19141, 1995